CAR-T race heads to Europe as Gilead, Novartis drugs score CHMP backing Gilead and Novartis CAR-T cancer drugs Yescarta and Kymriah won an EMA committee backing for marketing approval. Source: […]
England’s cost watchdogs shoot down Roche’s Ocrevus, the only approved therapy for PPMS Roche’s Ocrevus may be the only approved treatment for primary progressive multiple sclerosis, a tough-to-treat form of […]
After nearly 3 years, FDA lifts hold on Aptose cancer drug The FDA has lifted a clinical hold on Aptose Biosciences’ APTO-253 almost three years after it stopped the blood […]
Gemphire sparkles on third trial win for lead drug gemcabene Shares in Gemphire Therapeutics more than doubled after its lead drug gemcabene aced a midstage trial in patients with high […]
Amazon gets a drug distribution beachhead in PillPack buy Amazon purchased small pharmacy startup PillPack on Thursday, spooking investors in leading drug distribution and pharmacy giants. Source: Fierce Pharma Amazon […]
Newly discovered protein could boost hunt for drugs to treat sepsis and other inflammatory diseases The life-threatening disease sepsis is just one of several illnesses marked by overblown inflammation. Scientists […]
Sanofi, Advent finally shake hands on .2B European generics sale It’s official: Sanofi is finally ready to unload its European generics business. More than two months after disclosing that they […]
Newcomer Appello raises .5M for new Vanderbilt Parkinson’s drug Appello Pharmaceuticals raised $10.5 million to fund development of a new treatment for Parkinson’s disease licensed from Vanderbilt University’s Center for […]
Ready to challenge Novartis and Roche, Array scores FDA nod for melanoma combo Array will challenge pharma giants Novartis and Roche in its rollout of new cancer drugs Braftovi and […]
Rare disease specialist Spectrum eyes potential B-plus sale: Bloomberg Biopharma M&A has picked up this year with deals worth more than $34 billion so far, not counting Takeda’s $62 billion […]